DynaDuo 25 Tablet
By DynaDuo
Rx
10 Tablet in a Strip

Composition
Empagliflozin(25mg) + Linagliptin(5mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
May, 2027

liver
DynaDuo 25 Tablet is considered safe for use in individuals with liver disease. It is generally well-tolerated and does not usually require any dosage adjustments. Nevertheless, caution should be exercised when using DynaDuo 25 Tablet in cases of severe hepatic impairment, as there is limited data from studies conducted in such circumstances. It is advisable to consult with a healthcare professional before using this medication if you have severe liver issues.

kidney
DynaDuo 25 Tablet requires caution in patients with kidney disease. Adjusting the dose may be necessary. Avoid use in severe kidney disease or during dialysis. Kindly consult your doctor.

alcohol
It is not safe to drink alcohol when taking DynaDuo 25 Tablet.

driving
It is unknown if DynaDuo 25 Tablet affects driving. Refrain from driving if you have symptoms that impact concentration and reaction time.

pregnancy
DynaDuo 25 Tablet may not be safe to use during pregnancy. Animal studies have indicated potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. It is advisable to consult your doctor regarding its use.

breastfeeding
Caution should be taken while breastfeeding if you are considering using DynaDuo 25 Tablet. Limited data indicates potential risk of the drug passing into breastmilk and harming the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹119.9
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024
